Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a, interleukin (IL) IL-6 and IL-10, vascular cell adh...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Formato:	article
Lenguaje:	RU
Publicado:	IP Morozov P.V. 2020
Materias:	russian study victory ii arterial hypertension organ protection pulse wave velocity central arterial pressure central aortic pressure nephroprotection markers of endothelial damage ¬fixed combinations valsartan amlodipine hydrochlorothiazide vamloset® co-vamloset Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/749491d786994f6493162a7284467d61
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Ejemplares similares